Biochemical and Biophysical Research Communications · 2014 · 17 citations · 15 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionHormonal Cancer TherapyHormone ReceptorsHormone SignalingBreast Cancer ProgressionErythropoietin Receptor SignalingEstrogen Receptor ExpressionEstrogen Receptor SignalingEstrogen Receptor StatusHormone Receptor - Positive Breast CancerReceptors
The main function of Erythropoietin (EPO) and its receptor (EPOR) is the stimulation of erythropoiesis. Recombinant human EPO (rhEPO) is therefore used to treat anemia in cancer patients. However, clinical trials have indicated that rhEPO treatment might promote tumor progression and has a negative effect on patient survival. In addition, EPOR expression has been detected in several cancer forms. Using a newly produced anti-EPOR antibody that reliably detects the full-length isoform of the EPOR we show that breast cancer tissue and cells express the EPOR protein. rhEPO stimulation of cultured EPOR expressing breast cancer cells did not result in increased proliferation, overt activation of EPOR (receptor phosphorylation) or a consistent activation of canonical EPOR signaling pathway mediators such as JAK2, STAT3, STAT5, or AKT. However, EPOR knockdown experiments suggested functional EPO receptors in estrogen receptor positive (ERα(+)) breast cancer cells, as reduced EPOR expression resulted in decreased proliferation. This effect on proliferation was not seen in ERα negative cells. EPOR knockdown decreased ERα activity further supports a mechanism by which EPOR affects proliferation via ERα-mediated mechanisms. We show that EPOR protein is expressed in breast cancer cells, where it appears to promote proliferation by an EPO-independent mechanism in ERα expressing breast cancer cells.
15
Anti-Epo receptor antibodies do not predict Epo receptor expression
Steve Elliott, Leigh Busse, Michael Bass et al. · Blood · 2005 · 300 citations · Full text
Erythropoietin and erythropoietin receptor expression in human cancer.
Géza Ács, Péter Ács, S M Beckwith et al. · PubMed · 2001 · 241 citations
Induction of ID2 Expression by Hypoxia-inducible Factor-1
Tobias Löfstedt, Annika Jögi, Mikael Sigvardsson et al. · Journal of Biological Chemistry · 2004 · 127 citations · Full text
Robin D. Lester, Minji Jo, W. Marie Campana et al. · Journal of Biological Chemistry · 2005 · 122 citations · Full text